logo
  

Three Drug Distributors To Pay Up To $1.18 Bln To Settle New York Opioid Claims

AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK) agreed to pay up to $1.179 billion in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to settle opioid-related claims.

The agreement calls for the three major drug distributors to pay the combined settlement amount over the next 17 years, with payments beginning in two months, according to the New York state Attorney General's Office.

The New York Attorney General Letitia James reached a $230 million settlement agreement with Johnson & Johnson late last month, removing the company from the ongoing opioid trial. Johnson & Johnson agreed to stop selling opioids nationwide.

New York AG said that the trial against the three remaining defendants — Endo Health Solutions, Teva Pharmaceuticals USA, and Allergan Finance — is currently underway and will continue in state court.

The opioid crisis refers to the extensive overuse of opioid medications, both from medical prescriptions and from illegal sources. The crisis began in the United States in the late 1990s, when opioids were increasingly prescribed for pain management and resulted in a rise in overall opioid use throughout subsequent years.

From 1999 to 2017, more than 399,000 people reportedly died from drug overdoses that involved prescription and illicit opioids.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting its financial results for the second quarter on Thursday, Kellogg Co. (K) reaffirmed its currency-neutral adjusted earnings growth guidance for the full year 2021. For fiscal 2021, the company now projects currency-neutral adjusted earnings per share growth of about 1 to 2 percent... Moderna Inc. (MRNA) reported a profit for the second quarter compared to a loss in the previous year, reflecting surging revenues on commercial sales of the company's COVID-19 vaccine in the U.S. Quarterly earnings per share and revenues topped analysts' expectations. The company raised its 2021 sales forecast for its COVID-19 vaccine. New Widetech has recalled dehumidifiers sold under various brand names citing fire and burn risks, the U.S. Consumer Product Safety Commission said. The brand names include AeonAir, Amana, Haier, Honeywell, and Whirlpool, among others. The recall was initiated after New Widetech received reports of 107 incidents of the recalled dehumidifiers overheating and/or catching fire.
Follow RTT